v3.25.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Total revenues $ 4,777 $ 4,650
Gross profit 2,012 1,902
Selling, general, and administrative 1,040 1,038
Research and development 344 324
Total operating expenses 1,383 1,362
Operating income 629 540
Interest and other financial charges – net 110 122
Non-operating benefit (income) costs (74) (102)
Other (income) expense – net (99) 8
Income before income taxes 692 512
Benefit (provision) for income taxes (104) (124)
Net income 588 388
Net (income) loss attributable to noncontrolling interests (24) (14)
Net income attributable to GE HealthCare $ 564 $ 374
Earnings per share attributable to GE HealthCare:    
Basic (in dollars per share) $ 1.23 $ 0.82
Diluted (in dollars per share) $ 1.23 $ 0.81
Weighted-average number of shares outstanding:    
Basic (in shares) 457 456
Diluted (in shares) 459 459
Product    
Total revenues $ 3,117 $ 3,045
Cost of sales 1,963 1,967
Service    
Total revenues 1,660 1,605
Cost of sales $ 802 $ 782